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The authors explored the association of cigarette smoking with tuberculosis incidence, recurrence, andmortality.
A 14-year prospective cohort study (1992–2006) was carried out in 1,294,504 South Koreans. Participants were
grouped by smoking history, and the authors assessed tuberculosis incidence, mortality, and recurrence risk for
each group. Unadjusted and adjusted Cox proportional hazards models were used to investigate the association
between smoking history and the 3 outcomes of interest, adjusting for age and alcohol use. Compared with never
smokers, current smokers had increased mortality from tuberculosis among both men (adjusted hazard ratio
(HR) ¼ 1.6, 95% conﬁdence interval (CI): 1.3, 2.0) and women (HR ¼ 1.6, 95% CI: 1.0, 2.4). Current male
smokers had greater risk of incident tuberculosis than former smokers (HR ¼ 1.4, 95% CI: 1.3, 1.5), and risk
among current smokers increased with number of cigarettes smoked daily. In females, cigarette smoking was not
associated with incident tuberculosis. There was interaction between smoking and sex for incidence
(P ¼ 0.00047). The effect of smoking was generally reduced with adjustment for body mass index. Among
men, the highest alcohol consumption category (100 g/day) was associated with risk of incident tuberculosis
(HR ¼ 1.5, 95% CI: 1.3, 1.7). This study provides longitudinal evidence that smoking increases risk of incident
tuberculosis, mortality from tuberculosis, and tuberculosis recurrence.
alcohol drinking; incidence; mortality; recurrence; smoking; tuberculosis
Abbreviation: BMI, body mass index.
The possibility that smoking increases risk of tuberculosis
has significant disease control implications, as there are
presently 1.3 billion smokers in the world, and 9 million
incident tuberculosis cases and 1.7 million tuberculosis
deaths occur annually (1, 2). A number of studies, largely
in developing countries, have indicated that smoking may
contribute substantially to mortality from tuberculosis.
Based on a case-control study conducted in India from
2001 to 2003, Jha et al. (3) estimated that 50% of tubercu-
losis deaths in men were due to smoking. Smoking has been
associated with mortality from tuberculosis in other studies
carried out in India (4) and in studies conducted in China
(5), Hong Kong (6, 7), Taiwan (8), South Africa (9), and the
United Kingdom (10). Several recent literature reviews and
meta-analyses have synthesized evidence on risks of tuber-
culosis infection, disease, and mortality among smokers
(11–16). These reviews found that cigarette smoking is as-
sociated with an approximate doubling of risk for a positive
skin test, for having clinical evidence of disease, and for
tuberculosis mortality (15). Few studies have addressed in-
cidence, and most recent evidence on tuberculosis and
smoking comes from countries where tuberculosis is still
epidemic and health care is limited.
We explored the association between smoking and tuber-
culosis in a cohort study of 1.3 million people in South
Korea, the Korean Cancer Prevention Study. Study partici-
pants are largely employed and middle-class but still subject
to the persistently high risk of tuberculosis found in South
Korea (annual incidence rate ¼ 178/100,000 population in
2006) (2). South Korea provides screening and state-of-the-
art treatment for tuberculosis to all of its citizens. Because of
the richness of clinical data available, we were able to assess
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relations between smoking and the risks of incident tuber-
culosis, recurrent tuberculosis, and tuberculosis mortality.
MATERIALS AND METHODS
Study population
A description of the Korean Cancer Prevention Study has
been previously published (17). The study includes
1,329,525 South Koreans aged 30–95 years who partici-
pated in 1 biennial National Health Insurance Corporation
medical evaluation between 1992 and 1995. Enrollment
took place in 1992 (n ¼ 784,870), 1993 (n ¼ 367,903),
1994 (n ¼ 98,417), and 1995 (n ¼ 78,335).
To avoid bias due to preexisting disease in assessing the
association of smoking with tuberculosis mortality risk, we
excluded 904 participants who died before 1993, as well as
34,117 participants with missing information on alcohol use
or chest radiography. The final sample included 1,294,504
participants.
Because the study involved routinely collected data, con-
sent was not specifically obtained. The institutional review
boards of Yonsei University (Seoul, South Korea) and Johns
Hopkins Bloomberg School of Public Health (Baltimore,
Maryland) approved the study.
Data collection
Enrollees in the National Health Insurance Corporation un-
dergo standardized biennial examinations at local hospitals.
Questionnaire survey. During biennial visits made from
1992 through 1995 and from 1997 through 2000, partici-
pants reported their smoking habits, including number of
cigarettes smoked per day and duration of cigarette smoking
(in years) for current smokers, along with other health in-
formation, including alcohol consumption. History of past
or prevalent pulmonary tuberculosis was also included in the
questionnaire. Participants were asked whether they had
ever had any of a series of diseases, including pulmonary
tuberculosis, and whether they had ever received at least
3 months of treatment for tuberculosis.
Medical examination. Participants had a chest radiograph
(x-ray) taken at each visit, and findings were classified as
normal, nonactive, light pulmonary tuberculosis, moderate
pulmonary tuberculosis, severe pulmonary tuberculosis, sus-
pected pulmonary tuberculosis, or nontuberculosis disease.
Prevalent tuberculosis based on chest radiographywas defined
as a chest radiograph showing light, moderate, or severe pul-
monary tuberculosis. Weight and height measurements were
recorded while participants were wearing light clothing (17).
Medication data on pulmonary tuberculosis. Between
2001 and 2005, the following 8 primary antituberculosismed-
ications were listed in the medication database of the Health
Insurance Review and Assessment Service: isoniazid, rifam-
pin, ethambutol, pyrazinamide, prothionamide, cycloserine,
p-aminosalicylic acid, and streptomycin. Patients receiving at
least 3 medications were considered to have active tubercu-
losis. Of those receiving 3 medications, 73.8% received ri-
fampin, isoniazid, and either ethambutol or pyrazinamide.
Outpatient and hospitalization records. All hospitaliza-
tion and outpatient records from 1993–2006 were captured
by the National Health Insurance Corporation. However, not
all outpatient records for 1993–1997 were collected.
Death data. The vital status of all participants was
tracked from 1993 to 2006. For deceased participants, the
underlying cause of death as reported to the national statis-
tical office was obtained.
Follow-up and outcome classiﬁcation
The principal outcome variables were mortality from tu-
berculosis, incident tuberculosis, and recurrence of tubercu-
losis (Table 1). Mortality, outpatient, and hospitalization
codes for tuberculosis were International Classification of
Diseases, Tenth Revision, codes A15–A19.
The time frames over which these outcomes could be
assessed varied with data availability (Figure 1 and Table 1).
Mortality data were available for the full follow-up period,
while incidence and recurrence of tuberculosis could be
tracked only during the years 2001–2005, when medication
and outpatient visit data were available.
Analysis of incidence and recurrence was limited to par-
ticipants providing information on their smoking history
during 1997–2000; this resulted in the exclusion of
129,121 participants from the full cohort used for analysis
of mortality. Three measures of incident tuberculosis were
constructed: at least 1 hospitalization for tuberculosis, 2 or
more outpatient visits for tuberculosis, and receipt of at least
Table 1. Deﬁnitions of Tuberculosis Prevalence, Incidence, Recurrence, and Mortality Used in the Korean Cancer Prevention Study, 1992–2006
Variable Deﬁnition Time Period
Prevalence upon entry History of past or prevalent pulmonary TB as assessed by standard questionnaire.
Participants were asked whether they had ever had any of a series of diseases, including
pulmonary TB, and whether they had ever received at least 3 months of treatment.
1992–2000
Incidence Limited to participants who provided information on their smoking history during 1997–2000.
Four measures of incident TB were used: 1) at least 1 hospitalization for TB; 2) 2 or more
outpatient visits for TB; 3) receipt of at least 3 anti-TB medications; and 4) at least
1 of the above indicators.
2001–2005
Recurrence Limited to participants who provided information on their smoking history during 1997–2000.
Participants with prior or prevalent TB reported at the initial visit (1992–1995) or a follow-up
visit (1997–2000) were considered to have recurrent TB if they had any of the above
indicators for incident TB between 2001 and 2005.
2001–2005
Mortality Underlying cause of death as reported to the national statistical ofﬁce. 1993–2006
Abbreviation: TB, tuberculosis.
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3 antituberculosis medications. We also created a summary
measure for having at least 1 of these indicators. For re-
current tuberculosis, participants with prior or prevalent tu-
berculosis reported at the initial visit (1992–1995) or
a follow-up visit (1997–2000) were considered to have re-
current tuberculosis if they had had any indicators of inci-
dent tuberculosis between 2001 and 2005.
Statistical analysis
Smoking status was classified as never, current, or former
smoking, and current smokers were further classified as
smokers of 1–9, 10–19, or 20 cigarettes per day. Body
mass index (BMI; weight (kg)/height (m)2) was categorized
as <18.5, 18.5–19.9, 20.0–21.4, 21.5–22.9, 23.0–24.9,
25.0–26.4, 26.5–27.9, 28.0–29.9, 30–31.9, or 32.0. Indi-
cator variables corresponding to these categories were used
for the analysis. Cox proportional hazards models were used
to evaluate the association of baseline smoking status with
risk of tuberculosis incidence or death. For death from tu-
berculosis, data collected between 1993 and 2006 were
used. In analyzing incident tuberculosis from 2001 to
2005, our tuberculosis case definition included a report of
tuberculosis at hospitalization, a record of more than 2 out-
patient visits involving tuberculosis, and a record of use of at
least 3 types of antituberculosis medication (Table 1).
Analyses were stratified by sex, and results were adjusted
for age at enrollment (using age and the square of age) and
alcohol consumption (in 5 categories based on grams con-
sumed per day: 0, 1–24, 25–49, 50–99, and 100). Because
BMI is associated with both smoking and respiratory dis-
ease mortality, we also adjusted for BMI in the main models,
using the categorical variables. All Cox models were tested
for and met the proportional hazards assumption. In a sensi-
tivity analysis for mortality, we excluded the first 2 years of
follow-up to assess the potential role of reverse causality
(i.e., that smoking status changed because of diagnosis of
tuberculosis). We assessed modification of the effect of
smoking by including terms for the interaction of smoking
category indicators with indicator variables for sex and al-
cohol drinking (in 3 categories: 0, 1–<50, and 50 g/day).
All analyses were conducted using SAS, version 9.1 (SAS
Institute Inc., Cary, North Carolina).
RESULTS
The study population of 1,294,504 persons (827,333 men
and 467,171 women) was largely middle-aged (median age,
1992 1995
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Chest Radiograph 
1997 2000
Repeat
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Chest Radiograph 
2001 2005 2006
Outpatient Data;
Inpatient Data;
Medication Use
Mortality
Incidence
Recurrence
1992 2006
Figure 1. Timeline for data collection in the Korean Cancer Preven-
tion Study, 1992–2006.
Table 2. General Characteristics of Participants by Tuberculosis Status Upon Enrollment, Korean Cancer Prevention Study, 1992–1995
Men Women
Total
Population
Ever Having
Had TB at
Enrollmenta
Death
From TBb
Incident
TBc
Total
Population
Ever Having
Had TB at
Enrollmenta
Death
From TBb
Incident
TBc
No. %d No. % No. % No. % No. %d No. % No. % No. %
Age, years
30–49 538,469 65.1 12,448 2.3 107 0.0 4,107 0.8 238,148 51.0 3,548 1.5 7 0.0 1,599 0.7
50–64 241,578 29.2 8,373 3.5 248 0.1 3,552 1.8 171,313 36.7 1,879 1.1 43 0.0 2,086 1.3
65 47,286 5.7 2,285 4.8 304 0.6 998 3.1 57,710 12.3 827 1.4 118 0.2 924 1.9
Smoking status
Nonsmoker 172,040 20.8 4,736 2.8 107 0.1 1,561 1.0 437,885 93.7 5,873 1.3 119 0.0 4,200 1.0
Ex-smoker 171,732 20.8 6,565 3.8 188 0.1 1,846 1.2 9,997 2.1 191 1.9 22 0.2 144 1.7
Current smoker 483,561 58.4 11,805 2.4 364 0.1 5,250 1.2 19,289 4.1 190 1.0 27 0.1 265 1.6
Alcohol drinking,
g/day
Nondrinker 197,578 23.9 6,454 3.3 262 0.1 2,283 1.4 401,170 85.9 5,491 1.4 147 0.0 3,955 1.1
<50 565,977 68.4 15,244 2.7 370 0.1 5,679 1.1 65,936 14.1 762 1.2 21 0.0 653 1.1
50 63,778 7.7 1,408 2.2 27 0.0 695 1.2 65 0.0 1 1.5 0 0.0 1 1.6
Abbreviation: TB, tuberculosis.
a Information on prevalent TB by self-report and prevalent TB upon radiography was obtained from baseline data (1992–1995).
b Information on TB death was obtained from follow-up data (1993–2006).
c Information on incident TB was obtained from follow-up data (2001–2005).
d The percentages in the ‘‘Total Population’’ columns were calculated vertically; all other percentages in the table were calculated horizontally.
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45 years; interquartile range, 37–55). Cigarette smoking and
alcohol consumption were common among men but not
among women (Table 2); consistent with national data at
the time, the majority of men were smokers (18). At enroll-
ment, based on questionnaire reports and chest radiographs,
29,360 persons (23,106 men and 6,254 women) had current
Table 3. Effect of Smoking and Alcohol Drinking onMortality From Tuberculosis, Korean Cancer Prevention Study,
1993–2006
Men Women
No. of
Cases
Model 1a Model 2b No. of
Cases
Model 1a Model 2b
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Smoking status
Nonsmoker 107 1.0 1.0 119 1.0 1.0
Ex-smoker 188 1.45 1.14, 1.85 1.37 1.07, 1.75 22 2.16 1.35, 3.46 1.98 1.21, 3.24
Current smoker 364 1.58 1.27, 1.97 1.21 0.96, 1.51 27 1.55 1.00, 2.41 1.08 0.67, 1.74
Amount of smoking
(among current
smokers),
cigarettes/day
1–9 119 1.55 1.19, 2.00 1.17 0.89, 1.53 13 1.34 0.75, 2.41 1.02 0.55, 1.88
10–19 149 1.62 1.26, 2.08 1.24 0.96, 1.60 11 1.93 1.00, 3.70 1.10 0.50, 2.38
20 96 1.59 1.20, 2.10 1.22 0.91, 1.62 3 1.59 0.50, 5.02 1.33 0.42, 4.21
Alcohol drinking, g/day
Nondrinker 262 1.0 1.0 147 1.0 1.0
<50 370 0.83 0.70, 0.97 0.91 0.77, 1.08 21 0.72 0.45, 1.15 0.78 0.48, 1.26
50 27 1.00 0.66, 1.51 1.31 0.86, 1.97 No data
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Results were adjusted for age and age squared.
b Results were adjusted for age, age squared, and body mass index.
Table 4. Effect of Smoking and Alcohol Drinking on Incident Tuberculosis in Men and Women, Korean Cancer
Prevention Study, 2001–2005
Men Women
No. of
Cases
Model 1a Model 2b No. of
Cases
Model 1a Model 2b
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Smoking status
Nonsmoker 1,451 1.0 1.0 4,179 1.0 1.0
Ex-smoker 2,112 1.2 1.1, 1.3 1.2 1.1, 1.3 155 1.1 0.9, 1.3 1.1 0.9, 1.3
Current smoker 5,094 1.4 1.3, 1.5 1.2 1.2, 1.3 275 1.1 1.0, 1.2 1.0 0.9, 1.1
Amount of smokingc
(among current
smokers), cigarettes/day
1–9 1,064 1.2 1.1, 1.3 1.1 1.0, 1.2 No data
10–19 2,497 1.4 1.3, 1.5 1.2 1.2, 1.3 No data
20 1,527 1.5 1.4, 1.6 1.4 1.3, 1.5 No data
Alcohol drinking, g/day
Nondrinker 2,045 1.0 1.0 3,829 1.0 1.0
<25 5,087 0.9 0.9, 1.0 1.0 0.9, 1.1 778 1.0 0.9, 1.1 1.0 1.0, 1.1
25–49.9 722 1.0 0.9, 1.1 1.1 1.0, 1.2 No data
50–99.9 607 1.2 1.1, 1.3 1.3 1.2, 1.4 2 0.6 0.2, 2.5 0.6 0.2, 2.5
100.0 196 1.5 1.3, 1.7 1.6 1.4, 1.9 No data
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Results were adjusted for age and age squared.
b Results were adjusted for age, age squared, and body mass index.
c Six cases among men had missing information on amount of smoking.
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or previous tuberculosis. Among males, those with prevalent
or past tuberculosis upon enrollment comprised 2.4% of
current smokers and 3.8% of former smokers, while corre-
sponding figures for women were 1.0% and 1.9%, respec-
tively. During 14 years of follow-up, 827 deaths (659 in men
and 168 in women) from tuberculosis occurred (crude mor-
tality rate ¼ 5.0 per 100,000 person-years).
Initially, we assessed the relations of smoking and alcohol
consumption to mortality from tuberculosis (Table 3).
Among both men and women, smoking was associated with
increased mortality from tuberculosis. Risks were similar in
current and former smokers, and there was no indication of
increasing risk with increasing amount smoked daily for
current smokers. The estimates dropped substantially with
adjustment for BMI, particularly in current smokers. Risks
were similar in males and females, without evidence of
effect modification by sex.
Among men, we found that smoking was associated with
incident tuberculosis during 2001–2005 (Table 4). The find-
ings were similar for each of the 3 separate indicators of
incident tuberculosis (see Web Tables 1 and 2, which are
posted on the Journal’s Web site (http://aje.oxfordjournals.
org/)). Current smokers had greater risk of incident tuber-
culosis than former smokers, and risk among current
smokers increased with amount smoked daily. In men, the
hazard ratios for current smokers were somewhat lower with
adjustment for BMI. Drinking at least 50 g of alcohol daily
increased the risk of incident tuberculosis, and persons con-
suming at least 100 g daily had a 50% increased risk. There
was no indication of interaction between cigarette smoking
and alcohol consumption (P for interaction ¼ 0.368). By
contrast, in women, cigarette smoking was not associated
with incident tuberculosis (Table 4), and there was signifi-
cant interaction between smoking and sex for risk of inci-
dent tuberculosis (P for interaction ¼ 0.00047).
We also examined risk of tuberculosis recurrence among
67,003 participants (52,503 men and 14,500 women) with
prior tuberculosis on the basis of questionnaires and chest
radiographs completed in 1992–1995 or 1997–2000. During
follow-up between 2001 and 2005, 5,546 recurrent tubercu-
losis diagnoses were reported (4,529 in men and 1,017 in
women) (Table 5). Estimates were slightly attenuated by
BMI adjustment. Among men and women, smoking was
associated with increased risk of recurrence of tuberculosis,
though the increase was not significant for women. Among
men, consumption of at least 50 g of alcohol daily increased
risk of recurrence.
DISCUSSION
In this prospective cohort study of over 1.3 million South
Koreans, male current cigarette smokers had a 40% increased
risk of incident tuberculosis compared with nonsmokers and
were 55% more likely to die of tuberculosis. In women, find-
ings for mortality risk were similar, but current smoking was
not associated with incidence. Former smokers, both males
and females, were at increased risk of tuberculosis mortality
and incidence. Smokers also had greater risk of recurrence.
After receiving little emphasis for decades, the effect of
smoking on risk of tuberculosis has recently been addressed
in several large studies and in systematic reviews. Overall,
the various recent syntheses of evidence concur in find-
ing that smoking is associated with increased risk of tu-
berculosis, regardless of the disease outcome measure
Table 5. Effect of Smoking and Alcohol Drinking on Risk of Recurrent Tuberculosis in Men and Women, Korean
Cancer Prevention Study, 2001–2005
Men Women
No. of
Cases
Model 1a Model 2b No. of
Cases
Model 1a Model 2b
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Smoking status
Nonsmoker 720 1.0 1.0 942 1.0 1.0
Ex-smoker 1,400 1.3 1.1, 1.4 1.3 1.2, 1.4 34 1.2 0.9, 1.8 1.2 0.9, 1.8
Current smoker 2,409 1.3 1.2, 1.4 1.2 1.1, 1.3 41 1.2 0.8, 1.6 1.0 0.7, 1.4
Amount of smokingc
(among current
smokers), cigarettes/day
1–9 571 1.3 1.2, 1.5 1.2 1.1, 1.4 22 1.1 0.7, 1.7 0.9 0.6, 1.4
10–19 1,188 1.3 1.2, 1.4 1.2 1.1, 1.3 12 1.1 0.6, 2.0 0.8 0.5, 1.6
20 645 1.4 1.2, 1.5 1.3 1.2, 1.5 6 1.6 0.7, 3.6 1.4 0.6, 3.2
Alcohol drinking, g/day
Nondrinker 1,139 1.0 1.0 843 1.0 1.0
<50 3,008 0.9 0.9, 1.0 1.0 0.9, 1.1 174 1.0 0.8, 1.2 1.0 0.9, 1.2
50 382 1.2 1.0, 1.3 1.3 1.1, 1.4 No data
Abbreviations: CI, conﬁdence interval; HR, hazard ratio.
a Results were adjusted for age and age squared.
b Results were adjusted for age, age squared, and body mass index.
c Five cases among men and 1 case among women had missing information on amount of smoking.
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used: infection, clinical disease, or mortality (12, 13, 15).
Using a prospective cohort study design, we have added to
this evidence by demonstrating an association between
smoking and tuberculosis incidence among men and con-
firming prior findings on mortality and recurrence.
Only 2 other cohort studies have addressed the incidence
of tuberculosis. Leung et al. (7) tracked incidence of tuber-
culosis in a cohort of 42,655 elderly persons in Hong Kong.
The rate of case notification was 6 times higher in current
smokers than in never smokers; the adjusted hazard ratio for
pulmonary tuberculosis was 2.9 (95% confidence interval:
2.0, 4.1). The greater risk in the Hong Kong cohort as com-
pared with the South Korean cohort may reflect its greater
age or other differences between the 2 populations. In a
cohort study of 17,699 participants in a national survey in
Taiwan, current smoking was associated with a near-
doubling of risk of incident tuberculosis (8).
Patients with a history of a tuberculosis diagnosis are at
risk of a subsequent tuberculosis event (19), and smoking has
been reported to be an independent risk factor for relapse in
studies carried out in South India (20) and Brazil (21). In
men, we found significantly increased risks of recurrent
tuberculosis among current smokers and former smokers
(Table 5). The risks were similar in women, though not sta-
tistically significant. While we cannot determine whether
smoking increases risk of treatment failure or reactivation
of a second infection with Mycobacterium tuberculosis, the
heightened risk among smokers needs to be recognized in
providing treatment and follow-up for tuberculosis.
A smoking-associated increase in risk of mortality could
reflect an effect of smoking on incidence, risk of recurrence,
or disease severity. We found that smoking was associated
with increased risk of both incidence and recurrence, but we
could not address disease severity. Smoking has widespread
effects on lung structure and function and affects host de-
fenses both in the lung and systemically; therefore, it could
plausibly act to increase incidence or worsen the prognosis
of tuberculosis (22). Smoking is the dominant cause of
chronic obstructive pulmonary disease, and tuberculosis is
associated with airflow obstruction (23). Smoking-caused
obstruction in conjunction with obstruction related to tuber-
culosis may worsen prognosis. With regard to incidence,
smoking increases the risk of becoming infected with
M. tuberculosis (24), and recently infected patients are at
greatest risk of progression to active disease (25). Smoking
has been causally associated with the risk of other respiratory
infections, including pneumonia and influenza (26). Postu-
lated mechanisms include effects on clearance mechanisms
and immunologic responses to inhaled pathogens, as well as
the structural changes in the lung caused by smoking.
Regardless of the underlying mechanisms by which
smoking increases incidence of tuberculosis and affects its
natural history, our study and others document that smoking
is 1 modifiable contributor to mortality. In men and women,
smoking was associated with an approximately 50% in-
crease in risk of mortality from tuberculosis. Estimates in
other studies have been as high as a 4-fold increase (5),
although there is significant heterogeneity in the available
estimates for mortality (15). Thus, even in a country as
affluent as South Korea, which has a national health care
system, we estimate from this study’s data (assuming
a smoking prevalence of 60% and a hazard ratio of 1.5) that
approximately 25% of tuberculosis deaths in South Korean
men can be attributed to smoking (27).
We found that sex modified the risk of incident tubercu-
losis associated with smoking, such that women had no in-
crease in risk while male current smokers had an
approximately 50% increase in risk. However, male and
female current smokers had equally heightened risks of
death from tuberculosis (Table 2). Epidemiologic character-
istics of tuberculosis differ by sex, with men having a higher
prevalence at all ages in surveys conducted around the world
(28, 29). Thus, the effect modification of incidence by sex
could reflect the higher background rate of dormant infec-
tion in males. The comparability of mortality risks associ-
ated with smoking in males and females is consistent with
this hypothesis. Other studies published to date have not
addressed modification of the effect of smoking by sex.
Alcohol abuse, which is more frequent among smokers, is
a well-known risk factor for tuberculosis (30). In the present
study, heavy alcohol consumption was found to be signifi-
cantly associated with tuberculosis incidence in men,
though not with mortality. However, sample size posed
a limitation in the analyses of mortality and alcohol use.
We did not find any indication of interaction between smok-
ing and alcohol consumption.
Potential limitations of this study primarily reflect the
need to rely on self-reports for data on tobacco and alcohol
use and on medical database information for establishing the
diagnosis of tuberculosis, leading to concern about potential
misclassification of exposures and outcomes. Information
on smoking status was updated, however, and self-reporting
of smoking in South Korea has been shown to be valid when
compared with cotinine measurements (31). For establish-
ing the occurrence of incident tuberculosis, we used 3 dif-
ferent indicators based on outcomes unlikely to be subject to
misclassification and found similar results (Table 1). Our
definitions were intended to exclude persons being evalu-
ated for tuberculosis who did not actually have the disease.
Consequently, for incident disease, we required at least
2 outpatient visits or the prescription of at least 3 antituber-
culosis agents. For establishing a diagnosis of past tubercu-
losis, we relied partly on self-reports, which may be subject
to misclassification.
Smokers are more likely to stop smoking when they de-
velop respiratory symptoms above and beyond those nor-
mally associated with cigarette smoking (32). Thus,
assessments of smoking among patients recently diagnosed
with tuberculosis may underestimate the association be-
tween current smoking and active tuberculosis disease. Of
those participants with prevalent or past tuberculosis upon
enrollment, a greater percentage were former smokers
(28.9%) and a lower percentage were current smokers
(50.1%) compared with those without such a history
(20.5% and 58.7%, respectively). This pattern suggests that
reverse causality is present, in which smokers stop smoking
when tuberculosis symptoms arise or a tuberculosis diagno-
sis is confirmed.
We conducted the analyses with and without adjustment
for BMI, a covariate not considered in other studies of
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smoking and tuberculosis. We had previously shown a strong
inverse association between respiratory mortality and BMI
in this cohort (17), an association probably reflecting reverse
causation in part, and other investigators have found a sim-
ilar and quite strong inverse association for tuberculosis
mortality specifically (33, 34). In a study carried out in
Norway, however, Tverdal (33) did not find an indication
of reverse causality; the inverse association of BMI with
tuberculosis incidence persisted with little change through
the longest duration of follow-up, 10–19 years after enroll-
ment. While the basis for the association with BMI is un-
certain, smokers weigh somewhat less than nonsmokers,
and consequently low BMI is a potential confounder. Addi-
tionally, the effect of smoking on tuberculosis risk could be
mediated, at least in part, by the lower BMI of smokers.
In our study, BMI adjustment had a greater impact for
mortality than for incidence, which is consistent with a pos-
sible role of reverse causation in the association between BMI
and respiratory mortality (Tables 3 and 4). There is also a po-
tential for confounding. We observed that relations of BMI
with risk of both tuberculosis incidence and tuberculosis mor-
tality were approximately linear, and among men and
women, current smokers had average BMIs 0.36 and 0.52
units lower than those of never smokers, respectively. De-
creases in effect estimates with BMI adjustment might reflect
either confounding by BMI or mediation of smoking’s effect
by lowering BMI. The adjusted models provide an assess-
ment of the sensitivity of our estimates of the effect of smok-
ing, assuming that there is either confounding or an indirect
effect of smoking. Regardless, there is a persistent effect of
smoking on incidence with adjustment. The association of
BMI with risk of tuberculosis needs further research.
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